 | • レポートコード：QYR2104Z5691 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、トキソプラズマ症検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（検査装置、試薬消耗品）、用途別市場規模（病院、商業＆私立研究所、医師用オフィス）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・トキソプラズマ症検査の市場動向 ・企業の競争状況、市場シェア ・トキソプラズマ症検査の種類別市場規模（検査装置、試薬消耗品） ・トキソプラズマ症検査の用途別市場規模（病院、商業＆私立研究所、医師用オフィス） ・トキソプラズマ症検査の北米市場規模2016-2027（アメリカ、カナダ） ・トキソプラズマ症検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・トキソプラズマ症検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・トキソプラズマ症検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・トキソプラズマ症検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Affymetrix、Bio-Rad Laboratories、Beckman Coulter、Biomerica、Cepheid、Biotest、GenBio） ・結論 |
The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection.
Currently, North America dominates the global toxoplasmosis testing market, followed by Europe. This is due to the rising prevalence of infectious diseases and increasing demand for effective testing methods by diagnostics laboratories in these regions.
Market Analysis and Insights: Global Toxoplasmosis Testing Market
The global Toxoplasmosis Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Toxoplasmosis Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Toxoplasmosis Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Toxoplasmosis Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Toxoplasmosis Testing market.
Global Toxoplasmosis Testing Scope and Market Size
Toxoplasmosis Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Toxoplasmosis Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Testing Equipment
Reagent Consumables
Segment by Application
Hospitals
Commercial Or Private Laboratories
Physician Offices
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Affymetrix
Bio-Rad Laboratories
Beckman Coulter
Biomerica
Cepheid
Biotest
GenBio
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Toxoplasmosis Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Testing Equipment
1.2.3 Reagent Consumables
1.3 Market by Application
1.3.1 Global Toxoplasmosis Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Commercial Or Private Laboratories
1.3.4 Physician Offices
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Toxoplasmosis Testing Market Perspective (2016-2027)
2.2 Toxoplasmosis Testing Growth Trends by Regions
2.2.1 Toxoplasmosis Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Toxoplasmosis Testing Historic Market Share by Regions (2016-2021)
2.2.3 Toxoplasmosis Testing Forecasted Market Size by Regions (2022-2027)
2.3 Toxoplasmosis Testing Industry Dynamic
2.3.1 Toxoplasmosis Testing Market Trends
2.3.2 Toxoplasmosis Testing Market Drivers
2.3.3 Toxoplasmosis Testing Market Challenges
2.3.4 Toxoplasmosis Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Toxoplasmosis Testing Players by Revenue
3.1.1 Global Top Toxoplasmosis Testing Players by Revenue (2016-2021)
3.1.2 Global Toxoplasmosis Testing Revenue Market Share by Players (2016-2021)
3.2 Global Toxoplasmosis Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Toxoplasmosis Testing Revenue
3.4 Global Toxoplasmosis Testing Market Concentration Ratio
3.4.1 Global Toxoplasmosis Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Toxoplasmosis Testing Revenue in 2020
3.5 Toxoplasmosis Testing Key Players Head office and Area Served
3.6 Key Players Toxoplasmosis Testing Product Solution and Service
3.7 Date of Enter into Toxoplasmosis Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Toxoplasmosis Testing Breakdown Data by Type
4.1 Global Toxoplasmosis Testing Historic Market Size by Type (2016-2021)
4.2 Global Toxoplasmosis Testing Forecasted Market Size by Type (2022-2027)
5 Toxoplasmosis Testing Breakdown Data by Application
5.1 Global Toxoplasmosis Testing Historic Market Size by Application (2016-2021)
5.2 Global Toxoplasmosis Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Toxoplasmosis Testing Market Size (2016-2027)
6.2 North America Toxoplasmosis Testing Market Size by Type
6.2.1 North America Toxoplasmosis Testing Market Size by Type (2016-2021)
6.2.2 North America Toxoplasmosis Testing Market Size by Type (2022-2027)
6.2.3 North America Toxoplasmosis Testing Market Size by Type (2016-2027)
6.3 North America Toxoplasmosis Testing Market Size by Application
6.3.1 North America Toxoplasmosis Testing Market Size by Application (2016-2021)
6.3.2 North America Toxoplasmosis Testing Market Size by Application (2022-2027)
6.3.3 North America Toxoplasmosis Testing Market Size by Application (2016-2027)
6.4 North America Toxoplasmosis Testing Market Size by Country
6.4.1 North America Toxoplasmosis Testing Market Size by Country (2016-2021)
6.4.2 North America Toxoplasmosis Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Toxoplasmosis Testing Market Size (2016-2027)
7.2 Europe Toxoplasmosis Testing Market Size by Type
7.2.1 Europe Toxoplasmosis Testing Market Size by Type (2016-2021)
7.2.2 Europe Toxoplasmosis Testing Market Size by Type (2022-2027)
7.2.3 Europe Toxoplasmosis Testing Market Size by Type (2016-2027)
7.3 Europe Toxoplasmosis Testing Market Size by Application
7.3.1 Europe Toxoplasmosis Testing Market Size by Application (2016-2021)
7.3.2 Europe Toxoplasmosis Testing Market Size by Application (2022-2027)
7.3.3 Europe Toxoplasmosis Testing Market Size by Application (2016-2027)
7.4 Europe Toxoplasmosis Testing Market Size by Country
7.4.1 Europe Toxoplasmosis Testing Market Size by Country (2016-2021)
7.4.2 Europe Toxoplasmosis Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Toxoplasmosis Testing Market Size (2016-2027)
8.2 Asia-Pacific Toxoplasmosis Testing Market Size by Type
8.2.1 Asia-Pacific Toxoplasmosis Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Toxoplasmosis Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Toxoplasmosis Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Toxoplasmosis Testing Market Size by Application
8.3.1 Asia-Pacific Toxoplasmosis Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Toxoplasmosis Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Toxoplasmosis Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Toxoplasmosis Testing Market Size by Region
8.4.1 Asia-Pacific Toxoplasmosis Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Toxoplasmosis Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Toxoplasmosis Testing Market Size (2016-2027)
9.2 Latin America Toxoplasmosis Testing Market Size by Type
9.2.1 Latin America Toxoplasmosis Testing Market Size by Type (2016-2021)
9.2.2 Latin America Toxoplasmosis Testing Market Size by Type (2022-2027)
9.2.3 Latin America Toxoplasmosis Testing Market Size by Type (2016-2027)
9.3 Latin America Toxoplasmosis Testing Market Size by Application
9.3.1 Latin America Toxoplasmosis Testing Market Size by Application (2016-2021)
9.3.2 Latin America Toxoplasmosis Testing Market Size by Application (2022-2027)
9.3.3 Latin America Toxoplasmosis Testing Market Size by Application (2016-2027)
9.4 Latin America Toxoplasmosis Testing Market Size by Country
9.4.1 Latin America Toxoplasmosis Testing Market Size by Country (2016-2021)
9.4.2 Latin America Toxoplasmosis Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Toxoplasmosis Testing Market Size (2016-2027)
10.2 Middle East & Africa Toxoplasmosis Testing Market Size by Type
10.2.1 Middle East & Africa Toxoplasmosis Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Toxoplasmosis Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Toxoplasmosis Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Toxoplasmosis Testing Market Size by Application
10.3.1 Middle East & Africa Toxoplasmosis Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Toxoplasmosis Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Toxoplasmosis Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Toxoplasmosis Testing Market Size by Country
10.4.1 Middle East & Africa Toxoplasmosis Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Toxoplasmosis Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Toxoplasmosis Testing Introduction
11.1.4 Abbott Laboratories Revenue in Toxoplasmosis Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Details
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Toxoplasmosis Testing Introduction
11.2.4 Affymetrix Revenue in Toxoplasmosis Testing Business (2016-2021)
11.2.5 Affymetrix Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Toxoplasmosis Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Toxoplasmosis Testing Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Toxoplasmosis Testing Introduction
11.4.4 Beckman Coulter Revenue in Toxoplasmosis Testing Business (2016-2021)
11.4.5 Beckman Coulter Recent Development
11.5 Biomerica
11.5.1 Biomerica Company Details
11.5.2 Biomerica Business Overview
11.5.3 Biomerica Toxoplasmosis Testing Introduction
11.5.4 Biomerica Revenue in Toxoplasmosis Testing Business (2016-2021)
11.5.5 Biomerica Recent Development
11.6 Cepheid
11.6.1 Cepheid Company Details
11.6.2 Cepheid Business Overview
11.6.3 Cepheid Toxoplasmosis Testing Introduction
11.6.4 Cepheid Revenue in Toxoplasmosis Testing Business (2016-2021)
11.6.5 Cepheid Recent Development
11.7 Biotest
11.7.1 Biotest Company Details
11.7.2 Biotest Business Overview
11.7.3 Biotest Toxoplasmosis Testing Introduction
11.7.4 Biotest Revenue in Toxoplasmosis Testing Business (2016-2021)
11.7.5 Biotest Recent Development
11.8 GenBio
11.8.1 GenBio Company Details
11.8.2 GenBio Business Overview
11.8.3 GenBio Toxoplasmosis Testing Introduction
11.8.4 GenBio Revenue in Toxoplasmosis Testing Business (2016-2021)
11.8.5 GenBio Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Toxoplasmosis Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Testing Equipment
Table 3. Key Players of Reagent Consumables
Table 4. Global Toxoplasmosis Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Toxoplasmosis Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Toxoplasmosis Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Toxoplasmosis Testing Market Share by Regions (2016-2021)
Table 8. Global Toxoplasmosis Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Toxoplasmosis Testing Market Share by Regions (2022-2027)
Table 10. Toxoplasmosis Testing Market Trends
Table 11. Toxoplasmosis Testing Market Drivers
Table 12. Toxoplasmosis Testing Market Challenges
Table 13. Toxoplasmosis Testing Market Restraints
Table 14. Global Toxoplasmosis Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Toxoplasmosis Testing Market Share by Players (2016-2021)
Table 16. Global Top Toxoplasmosis Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Toxoplasmosis Testing as of 2020)
Table 17. Ranking of Global Top Toxoplasmosis Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Toxoplasmosis Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Toxoplasmosis Testing Product Solution and Service
Table 21. Date of Enter into Toxoplasmosis Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Toxoplasmosis Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Toxoplasmosis Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Toxoplasmosis Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Toxoplasmosis Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Toxoplasmosis Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Toxoplasmosis Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Toxoplasmosis Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Toxoplasmosis Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Toxoplasmosis Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Toxoplasmosis Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Toxoplasmosis Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Toxoplasmosis Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Toxoplasmosis Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Toxoplasmosis Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Toxoplasmosis Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Toxoplasmosis Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Toxoplasmosis Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Toxoplasmosis Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Toxoplasmosis Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Toxoplasmosis Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Toxoplasmosis Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Toxoplasmosis Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Toxoplasmosis Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Toxoplasmosis Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Toxoplasmosis Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Toxoplasmosis Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Toxoplasmosis Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Toxoplasmosis Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Toxoplasmosis Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Toxoplasmosis Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Toxoplasmosis Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Toxoplasmosis Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Toxoplasmosis Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Toxoplasmosis Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Toxoplasmosis Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Toxoplasmosis Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Toxoplasmosis Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Toxoplasmosis Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Toxoplasmosis Testing Product
Table 64. Abbott Laboratories Revenue in Toxoplasmosis Testing Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Affymetrix Company Details
Table 67. Affymetrix Business Overview
Table 68. Affymetrix Toxoplasmosis Testing Product
Table 69. Affymetrix Revenue in Toxoplasmosis Testing Business (2016-2021) & (US$ Million)
Table 70. Affymetrix Recent Development
Table 71. Bio-Rad Laboratories Company Details
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories Toxoplasmosis Testing Product
Table 74. Bio-Rad Laboratories Revenue in Toxoplasmosis Testing Business (2016-2021) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. Beckman Coulter Company Details
Table 77. Beckman Coulter Business Overview
Table 78. Beckman Coulter Toxoplasmosis Testing Product
Table 79. Beckman Coulter Revenue in Toxoplasmosis Testing Business (2016-2021) & (US$ Million)
Table 80. Beckman Coulter Recent Development
Table 81. Biomerica Company Details
Table 82. Biomerica Business Overview
Table 83. Biomerica Toxoplasmosis Testing Product
Table 84. Biomerica Revenue in Toxoplasmosis Testing Business (2016-2021) & (US$ Million)
Table 85. Biomerica Recent Development
Table 86. Cepheid Company Details
Table 87. Cepheid Business Overview
Table 88. Cepheid Toxoplasmosis Testing Product
Table 89. Cepheid Revenue in Toxoplasmosis Testing Business (2016-2021) & (US$ Million)
Table 90. Cepheid Recent Development
Table 91. Biotest Company Details
Table 92. Biotest Business Overview
Table 93. Biotest Toxoplasmosis Testing Product
Table 94. Biotest Revenue in Toxoplasmosis Testing Business (2016-2021) & (US$ Million)
Table 95. Biotest Recent Development
Table 96. GenBio Company Details
Table 97. GenBio Business Overview
Table 98. GenBio Revenue in Toxoplasmosis Testing Business (2016-2021) & (US$ Million)
Table 99. GenBio Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Toxoplasmosis Testing Market Share by Type: 2020 VS 2027
Figure 2. Testing Equipment Features
Figure 3. Reagent Consumables Features
Figure 4. Global Toxoplasmosis Testing Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Commercial Or Private Laboratories Case Studies
Figure 7. Physician Offices Case Studies
Figure 8. Toxoplasmosis Testing Report Years Considered
Figure 9. Global Toxoplasmosis Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Toxoplasmosis Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Toxoplasmosis Testing Market Share by Regions: 2020 VS 2027
Figure 12. Global Toxoplasmosis Testing Market Share by Regions (2022-2027)
Figure 13. Global Toxoplasmosis Testing Market Share by Players in 2020
Figure 14. Global Top Toxoplasmosis Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Toxoplasmosis Testing as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Toxoplasmosis Testing Revenue in 2020
Figure 16. Global Toxoplasmosis Testing Revenue Market Share by Type (2016-2021)
Figure 17. Global Toxoplasmosis Testing Revenue Market Share by Type (2022-2027)
Figure 18. North America Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Toxoplasmosis Testing Market Share by Type (2016-2027)
Figure 20. North America Toxoplasmosis Testing Market Share by Application (2016-2027)
Figure 21. North America Toxoplasmosis Testing Market Share by Country (2016-2027)
Figure 22. United States Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Toxoplasmosis Testing Market Share by Type (2016-2027)
Figure 26. Europe Toxoplasmosis Testing Market Share by Application (2016-2027)
Figure 27. Europe Toxoplasmosis Testing Market Share by Country (2016-2027)
Figure 28. Germany Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Toxoplasmosis Testing Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Toxoplasmosis Testing Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Toxoplasmosis Testing Market Share by Region (2016-2027)
Figure 38. China Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Toxoplasmosis Testing Market Share by Type (2016-2027)
Figure 46. Latin America Toxoplasmosis Testing Market Share by Application (2016-2027)
Figure 47. Latin America Toxoplasmosis Testing Market Share by Country (2016-2027)
Figure 48. Mexico Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Toxoplasmosis Testing Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Toxoplasmosis Testing Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Toxoplasmosis Testing Market Share by Country (2016-2027)
Figure 54. Turkey Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Toxoplasmosis Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Toxoplasmosis Testing Business (2016-2021)
Figure 58. Affymetrix Revenue Growth Rate in Toxoplasmosis Testing Business (2016-2021)
Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Toxoplasmosis Testing Business (2016-2021)
Figure 60. Beckman Coulter Revenue Growth Rate in Toxoplasmosis Testing Business (2016-2021)
Figure 61. Biomerica Revenue Growth Rate in Toxoplasmosis Testing Business (2016-2021)
Figure 62. Cepheid Revenue Growth Rate in Toxoplasmosis Testing Business (2016-2021)
Figure 63. Biotest Revenue Growth Rate in Toxoplasmosis Testing Business (2016-2021)
Figure 64. GenBio Revenue Growth Rate in Toxoplasmosis Testing Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界のトキソプラズマ症検査市場 2021：企業別、地域別、種類・用途別 The Toxoplasmosis Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 世界のトキソプラズマ症治療薬市場 2021：企業別、地域別、種類・用途別 The Drugs for Toxoplasmosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の診察室診断検査市場規模・現状・予測（2021年-2027年） Physician office diagnostic testing is similar to the point-of-care diagnostic testing which are carried out in physician’s office, hospital, home and others. The physician office diagnostic testing market is expected to grow at a rapid growth rate over the forecast period owing to the increasing se…
- 世界の診察室診断検査市場規模・現状・予測（2021年-2027年） Physician office diagnostic testing is similar to the point-of-care diagnostic testing which are carried out in physician’s office, hospital, home and others. The physician office diagnostic testing market is expected to grow at a rapid growth rate over the forecast period owing to the increasing se…
- 世界の血液検査市場規模・現状・予測（2021年-2027年） A blood test is the analysis of blood sample performed in a laboratory and the blood is usually taken from the vein in the arm through a needle, or through a finger prick to determine patient’s health status. Blood tests are very often used in health care to understand biochemical and physiological …